Skip to content

PLIANT THERAPEUTICS, INC.

PLRX

CIK 0001746473

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$145.81M
+29.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.38
+30.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$130.56M
Q1 May 2026
Cash
$22.19M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
61.92M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings